EP4420658A1 — A film coated tablet comprising empagliflozin
Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2024-08-28 · 2y expired
What this patent protects
The present invention relates to a film coated tablet comprising empagliflozin or a pharmaceutically acceptable salt thereof or crystalline polymorph thereof and at least one pharmaceutically acceptable excipient wherein used lubricant is sodium stearyl fumarate. The present inve…
USPTO Abstract
The present invention relates to a film coated tablet comprising empagliflozin or a pharmaceutically acceptable salt thereof or crystalline polymorph thereof and at least one pharmaceutically acceptable excipient wherein used lubricant is sodium stearyl fumarate. The present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient method of preparing the formulation.
Drugs covered by this patent
- Jardiance (empagliflozin) · Boehringer Ingelheim
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.